<DOC>
	<DOCNO>NCT00269880</DOCNO>
	<brief_summary>The purpose study compare safety effectiveness abciximab , anti-platelet therapy , versus placebo patient undergo percutaneous coronary intervention administer combination two different heparin regimen . Please see attached result .</brief_summary>
	<brief_title>A Study Comparing Efficacy Safety Abciximab , Anti-Platelet Therapy , Combination With Two Different Heparin Regimens Patients Undergoing Percutaneous Coronary Intervention .</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled trial compare efficacy safety abciximab , anti-platelet therapy , combination two different heparin regimens patient undergo percutaneous coronary intervention . Patients randomly assign one three treatment group : abciximab/low-dose weight-adjusted heparin , abciximab/standard-dose weight-adjusted heparin , placebo/standard-dose weight-adjusted heparin . The primary outcome study include number death , myocardial infarction , repeat revascularizations within 6 month , number death , myocardial infarction , severe myocardial ischemia lead urgent repeat percutaneous coronary intervention urgent coronary artery bypass surgery within 30 day . Please see attached result . Abciximab bolus plus 12-hour infusion standard-dose weight-adjusted heparin ; Abciximab bolus plus 12-hour infusion low-dose weight-adjusted heparin ; Placebo bolus plus 12-hour infusion standard-dose weight-adjusted heparin</detailed_description>
	<mesh_term>Abciximab</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Immunoglobulin Fab Fragments</mesh_term>
	<criteria>Patients refer elective urgent percutaneous coronary intervention FDAapproved device Having target artery ( native graft ) stenosis 60 % visual estimation Patients unstable angina/nonQwave myocardial infarction meeting EPIC criterion within previous 24 hour , acute Qwave myocardial infarction meeting EPIC criterion onset chest pain within previous 24 hour With active internal bleeding , condition may increase risk bleeding , currently receive administration oral anticoagulant time study entry With confirmed hypertension systolic blood pressure &gt; 180 mm Hg diastolic blood pressure &gt; 100 mm Hg Having percutaneous coronary intervention within previous 3 month Having unprotected leave main coronary artery stenosis &gt; 50 %</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Angioplasty , Transluminal , Percutaneous coronary</keyword>
</DOC>